- Home
- EVC vs FENC Comparison
EVC vs FENC Comparison
Compare EVC & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EVC | FENC |
|---|---|---|
| Founded | 1996 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Broadcasting | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 273.8M | 263.3M |
| IPO Year | 2000 | 2010 |
Fundamental Metrics
Financial Performance| Metric | EVC | FENC |
|---|---|---|
| Price | $3.02 | $7.80 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $15.00 |
| AVG Volume (30 Days) | ★ 377.3K | 113.2K |
| Earning Date | 06-10-2026 | 01-01-0001 |
| Dividend Yield | ★ 6.69% | N/A |
| EPS Growth | 47.59 | ★ 96.67 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $536,034,000.00 | $47,538,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $70.78 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 123.69 |
| 52 Week Low | $1.76 | $4.68 |
| 52 Week High | $3.68 | $9.92 |
Technical Indicators
Market Signals| Indicator | EVC | FENC |
|---|---|---|
| Relative Strength Index (RSI) | 48.51 | 45.61 |
| Support Level | $2.85 | $7.44 |
| Resistance Level | $3.17 | $8.27 |
| Average True Range (ATR) | 0.17 | 0.45 |
| MACD | -0.01 | -0.09 |
| Stochastic Oscillator | 18.02 | 27.70 |
Price Performance
Historical ComparisonAbout EVC Entravision Communications Corporation
Entravision Communications Corp owns and operates Spanish language television and radio stations in the United States. The Company also owns and operates a smaller group of television stations that broadcast English language programming and has operations that provide programmatic advertising technology and services. The Company has organized its operations into two reportable segments. Its media segment includes its television, radio, and digital marketing operations. Its advertising and technology services segment provides programmatic advertising and technology services. The company generates the majority of its revenue from the Media segment. Geographically, the company generates the majority of its revenue from the United States.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.